Lack of safety data prompts guidance on oestrogen therapy A summary of evidence is out for prescribing oestrogen treatments for the estimated 75% of breast cancer patients who develop genitourinary symptoms.
Should the breast screening age be lowered? While the question has again been put forward, Australian experts remain unconvinced, saying participation among target groups is more important.
Patients given immediate access to results on MHR The DoHAC has scrapped a seven-day delay in patients viewing pathology and diagnostic imaging results, against the advice of medical colleges.
How can Australia increase BreastScreen participation? With more than one in two eligible women not taking part in the preventive screening program, the RACGP has suggested ways to boost engagement.
Feminist language being hijacked to market medical tests Narratives around empowerment and women’s rights are being co-opted to market interventions not backed by evidence, according to new research.
Support for RACGP warning on immediate pathology results Pathologists say removing the seven-day delay on uploading reports to My Health Record may lead to misinformation and patient distress.
Make breast density reporting mandatory: RANZCR The radiologist body is calling for an expansion of mammogram services, and a GP expert agrees it will help patients make more informed choices.
Should patients be able to immediately access results via MHR? The DoH is looking to modernise My Health Record to include the default sharing of pathology and imaging reports, but the RACGP has concerns.
Study calls for population-wide genomic screening Expanded testing for three genetic conditions could save lives and money, Monash University research suggests.
Cancer screening may not extend life: Study But a more personalised approach that matches screening recommendations to individual risk profiles may help overcome existing shortcomings.